GILUPI GmbH is a startup based in Germany. Brouky records 1 investor associated with the company.
GILUPI GmbH develops medical devices and workflows to capture and analyze circulating tumor cells (CTCs) directly from patients' blood. Its flagship product is an in vivo capture device (a functionalized wire) used for cancer diagnostics and monitoring.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.